Home > Financial Ratios > LYKA LABS

LYKA LABS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 1.431.800.982.273.18

What is the latest Fixed Capital/Sales ratio of LYKA LABS ?

The latest Fixed Capital/Sales ratio of LYKA LABS is 1.43 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20241.43
Mar20231.80
Mar20220.98
Mar20212.27
Mar20203.18

How is Fixed Capital/Sales of LYKA LABS Trending?

Years Fixed Capital/Sales % Change
Mar2024 1.43
-20.56
Mar2023 1.8
83.67
Mar2022 0.98
-56.83
Mar2021 2.27
-28.62
Mar2020 3.18 -

Other Financial Ratios of LYKA LABS


Compare Fixed Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹405.9 Cr -2.7% -3.8% 7.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
CIPLA ₹123,329.0 Cr 1.1% 1.8% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-2.7%

-3.8%

7.9%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses